Activities of Stine BOSSE
Plenary speeches (4)
One-minute speeches on matters of political importance
Urgent need to revise the medical devices regulation (debate)
General budget of the European Union for the financial year 2025 – all sections (debate)
Foreign interference and espionage by third country actors in European universities (debate)
Oral questions (1)
The Commission’s plans to include the revision of the outstanding proposals on animal welfare in its work plan for 2025
Written questions (2)
Continued availability of operating grants under the 2025 EU4Health work programme
Unfair competition in the aviation sector owing to Russian sanctions
Amendments (3)
Amendment 32 #
2024/2019(DEC)
Draft opinion
Paragraph 8 a (new)
Paragraph 8 a (new)
8 a. Considers that civil society and NGOs play an instrumental role in shaping policies that benefit society and our environment; recalls the commitment of the Commission in its political guidelines to step up its engagement with civil society organisations that have expertise and an important role to play in defending specific societal issues and upholding human rights; urges the Commission to revise its guidelines1a from May 2024 in order to ensure the continuation of the funding of NGO activities, including advocacy, under the LIFE programme; considers that discontinuation of this funding for all NGO activities would seriously undermine the voice of civil society in the public debate and would cause a severe reputational risk for the Commission; _________________ 1a Guidance on funding for activities related to the development, implementation, monitoring and enforcement of Union legislation and policy
Amendment 304 #
2023/0453(COD)
Proposal for a regulation
Article 5 – paragraph 2
Article 5 – paragraph 2
2. Where the Commission or the Agencies hold data or information referred to in Article 3(2), they shall make that data available to the ECHA, in a standard format, where available, together with the relevant context data as referred to in Article 4(4), point (c). The Commission and the Agencies shall indicate whether that data or information is made available to the public or confidential in accordance with the provisions on confidentiality under the originating Union act.
Amendment 524 #
2023/0453(COD)
Proposal for a regulation
Article 22 – paragraph 7 a (new)
Article 22 – paragraph 7 a (new)
7 a. The requirements outlined in this article do not apply to substances that are manufactured, imported, or used for Scientific Research and Development (SR&D) or Product and Process-Oriented Research and Development (PPORD), each as defined in Regulation (EC) No 1907/2006 (REACH), when used in, or for, research in, and development of, medicinal products.